In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.

Rawstron, A C; Barrans, S L; Blythe, D; English, A; Richards, S J; Fenton, J A; Davies, F E; Child, J A; Jack, A S; Morgan, G J

Rawstron, A C; Barrans, S L; Blythe, D; English, A; Richards, S J; Fenton, J A; Davies, F E; Child, J A; Jack, A S; Morgan, G J.

Affiliation

Rawstron AC; HMDS, The General Infirmary at Leeds, Leeds, UK. andy.rawstron@newscientist.net

Br J Haematol ; 113(3): 794-802, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11380472

Subject(s)

Integrin alpha Chains; Leukocyte Common Antigens/analysis; Multiple Myeloma/pathology; Plasma Cells/pathology; Receptors, Fibronectin/analysis; Antigens, CD/analysis; Biomarkers, Tumor/analysis; CD79 Antigens; Cell Differentiation; Cell Division; Flow Cytometry; Humans; Immunophenotyping; Lymphocyte Function-Associated Antigen-1/analysis; Multiple Myeloma/immunology; Multiple Myeloma/metabolism; Plasma Cells/chemistry; Plasma Cells/immunology; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasma Cells / Receptors, Fibronectin / Leukocyte Common Antigens / Integrin alpha Chains / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Haematol Year: 2001 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links